This review summarizes the current state and future directions of mechanical circulatory support for end-stage heart disease.
Summarizes current MCS options for end-stage HF; leaves open optimal device selection and long-term outcomes for prospective trials.
Mechanical circulatory support of the failing heart has become an important means of treating end-stage heart disease. This rapidly growing therapeutic field has produced impressive clinical outcomes and has great potential to help thousands of otherwise terminal patients worldwide. In this review, we examine the state of the art of mechanical circulatory support: current practice, totally implantable systems of the future, evolving biventricular support mechanisms, the potential for myocardial recovery and adjunctive treatment methods, and miniaturized devices with expanded indications for therapy.
No takes yet. Share an insight, caveat, or question.
Mallidi et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: